COGNICURRENT

Paweł Gruza, an advisor to Karol Nawrocki, is under investigation for allegedly profiting from insider trading involving confidential information related to a biotechnology company.

The first human clinical trial aimed at reversing aging processes has begun, announced by Dr. David Sinclair at the World Government Summit.

President Putin emphasizes the strategic importance of biotechnology supported by AI for Russia's industrial sovereignty during the Future Technologies Forum in Moscow.

Polish universities are set to receive significant support to adapt their educational offerings towards critical technologies that will strengthen economic resilience.

Novo Nordisk has released data from a study on a weight loss drug developed in collaboration with Chinese company United Biotechnology, showing significant weight loss among participants.

Colossal Biosciences celebrates a milestone in its project of resurrecting extinct species as genetically recreated ancient wolves have reached adulthood and begun hunting in packs, indicating a hopeful future for the species.

Kerecis is set to make a substantial payment to the Icelandic state, improving the financial outlook by converting a deficit into a surplus.

Brazilian company Legun Biotecnologia is innovating in public sanitation by using drones to apply biological treatment in stabilization ponds.

The article discusses the potential for new crops developed through modern genetic modification techniques to be cultivated in the European Union, and the mixed reactions these developments spark.

Chinese scientists have developed a gene-edited tomato that emits a buttered popcorn aroma by silencing specific genes using the CRISPR/Cas9 technique.

A Czech scientist asserts that the DNA vaccine will not bring about significant changes.

The prices of laboratory monkeys in China for drug testing have surged dramatically, exceeding the average annual salary in the country.

Argentina's universities are introducing new degree programs focused on technology, health, and digital finance for the 2026 academic cycle.

Kos Biotechnology Partners has completed a funding round for the New York-based biopharmaceutical company Epikast, which has key operations in Athens.

Argentinian universities are introducing new degree programs in response to the evolving job market, including areas such as artificial intelligence and biotechnology.

International and Greek pharmaceutical mergers and acquisitions are on the rise, focusing on innovative drugs and expiring patents.

Biologists in Alaska have discovered 26 new species of extremophiles in permafrost, potentially offering technological innovations for the U.S. military.

Manuel Rosasco, general manager of Stine Argentina, emphasizes the need for biotechnological advancements and reduced taxation to enhance Argentina's agricultural productivity against Brazil.

Only 33 of the initially selected 57 companies will receive state subsidies for biotechnology and robotics, with the majority of funds remaining for other programs.

Lithuanian researchers are exploring alternative methods to traditional injectable vaccines, raising discussions about vaccine accessibility and production challenges.

Farmers from Rurópolis, Placas, and Trairão attended the 1st Symposium and Field Day focused on banana cultivation, highlighting its importance in Brazil.

The Cheongju Kangsou Research and Development Special Zone in Chungcheongbuk-do, South Korea, is rapidly developing as a collaborative hub for academia, research institutions, and businesses to foster high-value-added scientific technologies and entrepreneurship.

The TV series "The Beauty" by Ryan Murphy explores the dark side of the pursuit of perfection and beauty in a narrative filled with horror and ethical dilemmas.

The article discusses the evolving trend in cosmetics towards sustainable marine ingredients and biotechnology to protect ocean ecosystems.

Hyundai ADM has become the first in the world to identify a multi-targeting effect that simultaneously blocks three core elements that lead to cancer cell metastasis.

A blast at a biotechnology factory in Shanxi province, China, has resulted in eight fatalities and an investigation into the incident is underway.

An explosion at a biotechnology factory in Shanxi province, China, resulted in the deaths of eight people, with the legal representative of the company in custody.

An explosion at a biotechnology factory in northern China resulted in at least seven fatalities and one person missing, prompting active search and rescue operations.

Researchers in Uppsala are experimenting with genetically modified bacteria that produce colored spider silk proteins, leading to the creation of vibrantly dyed yet mechanically strong fibers for future clothing.

The article discusses the implications of gene editing technology showcased during the 2nd International Genome Editing Summit in Hong Kong, particularly focusing on the controversial announcement of the birth of gene-edited twins by scientist He Jiankui.

Argentina is under significant pressure to ratify the Patent Cooperation Treaty by April 30 as part of its agreement with the United States, which includes eliminating certain biotechnology and pharmaceutical patenting resolutions.

Argentinian company Bioceres SA faces financial collapse and legal actions as it struggles with embargoes, executions, and preventive contests, impacting its presence on Nasdaq.

Researchers at Tallinn University of Technology have discovered that the red yeast Rhodotorula toruloides can produce sugar-based polymers as a sustainable alternative to petroleum-based materials.

Documents from the U.S. Department of Justice reveal emails exchanged between financier Jeffrey Epstein and programmer Brian Bishop in 2018 regarding the creation of the 'first living human designer baby.'

A research team from the U.S. Department of Energy has developed a method to convert sugar into a chemical that could generate billions in revenue, as presented in a recent study published in Nature Communications.

The first meeting of the Presidential Health Council in Poland focused on ensuring a stable drug supply for patients, involving public administration, academic experts, and industry representatives.

San Sebastián is replacing a failed leisure complex with a biotechnology hub, set to start operations in early 2027 after a €90 million investment.

A phase 1/2 study for a novel vaccine aimed at protecting against the effects of fentanyl will begin in early 2026 in the Netherlands with around 40 healthy adult volunteers.

The article outlines the ten key factors contributing to Shanghai's economic miracle, particularly highlighting the dominant sectors of tourism, biotechnology, real estate, and services, which together generate substantial annual revenues.